Zacks Research Weighs in on Amdocs' Q4 Earnings (NASDAQ:DOX)

Key Points

• Zacks Research lowered its Amdocs Q4 2027 EPS estimate to $1.83 from $1.87, while projecting Q1 2028 EPS of $1.88. The current full-year consensus estimate is $6.57 per share.
• Amdocs’ latest quarterly results met expectations at $1.84 EPS, while revenue of $1.17 billion came in slightly below forecasts but increased 2.7% year over year.
• The stock carries a consensus “Hold” rating with an $86.67 price target, and Amdocs declared a quarterly dividend of $0.569 per share, representing a 3.6% annualized yield.

Amdocs Limited (NASDAQ:DOX - Free Report) - Analysts at Zacks Research reduced their Q4 2027 earnings per share estimates for Amdocs in a report released on Wednesday, August 26th. Zacks Research analyst Team now anticipates that the technology company will post earnings of $1.83 per share for the quarter, down from their prior estimate of $1.87. The consensus estimate for Amdocs' current full-year earnings is $6.57 per share. Zacks Research also issued estimates for Amdocs' Q1 2028 earnings at $1.88 EPS.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its earnings results on Thursday, August 6th. The technology company reported $1.84 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.84. Amdocs had a return on equity of 20.28% and a net margin of 9.75%.The company had revenue of $1.17 billion during the quarter, compared to analysts' expectations of $1.18 billion. During the same period in the prior year, the business earned $1.72 EPS. The firm's quarterly revenue was up 2.7% on a year-over-year basis.

DOX has been the subject of several other reports. Stifel Nicolaus cut their price objective on shares of Amdocs from $88.00 to $71.00 and set a "buy" rating for the company in a research report on Thursday, May 14th. KeyCorp started coverage on shares of Amdocs in a research note on Monday, June 29th. They issued a "sector weight" rating for the company. Cfra lowered shares of Amdocs to a "sell" rating in a research report on Thursday, May 14th. Wall Street Zen cut Amdocs from a "buy" rating to a "hold" rating in a report on Sunday, July 5th. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of Amdocs in a research note on Wednesday, August 5th. Three investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Amdocs currently has an average rating of "Hold" and a consensus price target of $86.67.

Amdocs Trading Up 0.7%

Shares of DOX stock opened at $62.70 on Friday. The company's 50-day moving average price is $54.87 and its 200-day moving average price is $61.20. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23. The stock has a market cap of $6.77 billion, a price-to-earnings ratio of 14.93, a PEG ratio of 1.08 and a beta of 0.40. Amdocs has a twelve month low of $49.74 and a twelve month high of $87.10.

Amdocs Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be given a dividend of $0.569 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.6%. Amdocs's dividend payout ratio (DPR) is presently 54.05%.

Institutional Trading of Amdocs

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Royal Bank of Canada lifted its stake in Amdocs by 14.9% during the 1st quarter. Royal Bank of Canada now owns 446,125 shares of the technology company's stock worth $29,114,000 after acquiring an additional 57,740 shares in the last quarter. Renaissance Technologies LLC grew its position in Amdocs by 429.6% in the 1st quarter. Renaissance Technologies LLC now owns 291,800 shares of the technology company's stock valued at $19,043,000 after acquiring an additional 236,700 shares in the last quarter. BNP Paribas Financial Markets grew its position in Amdocs by 85.4% in the 4th quarter. BNP Paribas Financial Markets now owns 201,982 shares of the technology company's stock valued at $16,262,000 after acquiring an additional 93,036 shares in the last quarter. Arbejdsmarkedets Tillaegspension increased its stake in Amdocs by 17.5% during the first quarter. Arbejdsmarkedets Tillaegspension now owns 354,383 shares of the technology company's stock worth $23,127,000 after purchasing an additional 52,906 shares during the period. Finally, Wedge Capital Management L L P NC increased its stake in Amdocs by 39.2% during the second quarter. Wedge Capital Management L L P NC now owns 82,765 shares of the technology company's stock worth $4,183,000 after purchasing an additional 23,315 shares during the period. Hedge funds and other institutional investors own 92.02% of the company's stock.

Amdocs Company Profile

Amdocs NASDAQ: DOX is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs' product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra'anana, Israel.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source